Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Dental Society, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Stem Cell Rev Rep. 2024 Apr;20(3):637-655. doi: 10.1007/s12015-024-10676-9. Epub 2024 Jan 25.
Cleft lip and/or palate (CLP) is a prevalent congenital craniofacial abnormality that can lead to difficulties in eating, speaking, hearing, and psychological distress. The traditional approach for treating CLP involves bone graft surgery, which has limitations, post-surgical complications, and donor site morbidity. However, regenerative medicine has emerged as a promising alternative, employing a combination of stem cells, growth factors, and scaffolds to promote tissue regeneration. This review aims to provide a comprehensive overview of stem cell-based regenerative approaches in the management of CLP. A thorough search was conducted in the Medline/PubMed and Scopus databases, including cohort studies, randomized controlled trials, case series, case controls, case reports, and animal studies. The identified studies were categorized into two main groups: clinical studies involving human subjects and in vivo studies using animal models. While there are only a limited number of studies investigating the combined use of stem cells and scaffolds for CLP treatment, they have shown promising results. Various types of stem cells have been utilized in conjunction with scaffolds. Importantly, regenerative methods have been successfully applied to patients across a broad range of age groups. The collective findings derived from the reviewed studies consistently support the notion that regenerative medicine holds potential advantages over conventional bone grafting and represents a promising therapeutic option for CLP. However, future well-designed clinical trials, encompassing diverse combinations of stem cells and scaffolds, are warranted to establish the clinical efficacy of these interventions with a larger number of patients.
唇腭裂(CLP)是一种常见的先天性颅面畸形,可导致进食、说话、听力和心理困扰困难。传统的 CLP 治疗方法包括骨移植手术,但存在局限性、术后并发症和供体部位发病率等问题。然而,再生医学作为一种有前途的替代方法,结合了干细胞、生长因子和支架,以促进组织再生。本综述旨在全面概述干细胞再生方法在 CLP 管理中的应用。在 Medline/PubMed 和 Scopus 数据库中进行了全面检索,包括队列研究、随机对照试验、病例系列、病例对照、病例报告和动物研究。确定的研究分为两组:涉及人类受试者的临床研究和使用动物模型的体内研究。虽然只有少数研究调查了干细胞和支架联合用于 CLP 治疗的情况,但它们已经显示出了有前途的结果。各种类型的干细胞与支架结合使用。重要的是,再生方法已成功应用于广泛年龄组的患者。从综述研究中得出的综合结果一致支持再生医学优于传统骨移植的观点,并代表了 CLP 的一种有前途的治疗选择。然而,需要未来进行精心设计的临床试验,涵盖更多患者的不同干细胞和支架组合,以确定这些干预措施的临床疗效。